Evidence from the ‘PROspective MulticEnTer RadIcal Cystectomy Series 2011 (PROMETRICS 2011)’ Study: How are Preoperative Patient Characteristics Associated with Urinary Diversion Type After Radical Cystectomy for Bladder Cancer?

Annals of Surgical Oncology

Volumn 22, Issue 3, 2015, Pages 1032-1042

  Schmid, Marianne ^a,b   Rink, Michael ^a   Traumann, Miriam ^a   Bastian, Patrick J ^c   Bartsch, Georg ^d   Ellinger, Jörg ^e   Grimm, Marc Oliver ^f   Hadaschik, Boris ^g   Haferkamp, Axel ^d   Hakenberg, Oliver W ^h   Aziz, Atiqullah ⁱ   Hartmann, Florian ^f   Herrmann, Edwin ^j   Hohenfellner, Markus ^g   Janetschek, Günter ^k   Gierth, Michael ⁱ   Pahernik, Sasc ha ^g   Protzel, Chris ^h   Roigas, Jan ^l   Gördük, Murat ^l   Lusuardi, Lukas ^k   May, Matthias ^m   Trinh, Quoc Dien ^b   Fisch, Margit ^a   Chun, Felix K H ^a   more..

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Golzheim Paracelsus Clinic   (Germany)

^d GOETHE UNIVERSITY   (Germany)

^e UNIVERSITY OF BONN   (Germany)

^f FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^g UNIVERSITY OF HEIDELBERG   (Germany)

^h UNIVERSITY OF ROSTOCK   (Germany)

ⁱ UNIVERSITY OF REGENSBURG   (Germany)

^j UNIVERSITY OF MÜNSTER   (Germany)

^k PARACELSUS MEDICAL UNIVERSITY   (Austria)

^l VIVANTES KLINIKUM IM FRIEDRICHSHAIN   (Germany)

^m Department of Urology   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; AMERICAN SOCIETY OF ANESTHESIOLOGISTS SCORE; ARTICLE; BLADDER CANCER; CANCER CHEMOTHERAPY; CHARLSON COMORBIDITY INDEX; CONTINENT CUTANEOUS POUCH; CYSTECTOMY; FEMALE; HUMAN; HUMAN TISSUE; ILEAL CONDUIT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; ORTHOTOPIC NEOBLADDER; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; SCORING SYSTEM; SEX RATIO; TRANSFUSION; URETER SURGERY; URETEROCUTANEOSTOMY; URINARY DIVERSION; URINARY TRACT SURGERY; VERY ELDERLY; ADVERSE EFFECTS; CANCER GRADING; CANCER STAGING; CLINICAL TRIAL; COMORBIDITY; FOLLOW UP; MULTICENTER STUDY; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; QUALITY OF LIFE; SURVIVAL RATE; URINARY BLADDER NEOPLASMS;

AGED; AGED, 80 AND OVER; COMORBIDITY; CYSTECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; SURVIVAL RATE; URINARY BLADDER NEOPLASMS; URINARY DIVERSION;

EID: 84924935662     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-014-4029-3     Document Type: Article

References (39)

1. International Agency for Research on Cancer, World Health Organisation. GLOBOCAN 2008: cancer incidence, mortality, prevalence and disability-adjusted life years (DALY’s) worldwide in 2008. Lyon: IARC Press; 2010.
2. Ploeg M, Aben KK, Kiemeney LA. The present and future burden of urinary bladder cancer in the world. World J Urol. 2009;27(3):289-293.
3. Stenzl A, Cowan NC, De Santis M, et al. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Eur Urol. 2011;59(6):1009-1018.
4. Bostrom PJ, Kossi J, Laato M, Nurmi M. Risk factors for mortality and morbidity related to radical cystectomy. BJU Int. 2009;103(2):191-196.
5. Chang SS, Cookson MS, Baumgartner RG, Wells N, Smith JA Jr. Analysis of early complications after radical cystectomy: results of a collaborative care pathway. J Urol. 2002;167(5):2012-2016.
6. Hautmann RE, de Petriconi RC, Volkmer BG. Lessons learned from 1,000 neobladders: the 90-day complication rate. J Urol. 2010;184(3):990-994; quiz 1235.
7. Hollenbeck BK, Miller DC, Taub D, et al. Identifying risk factors for potentially avoidable complications following radical cystectomy. J Urol. 2005;174(4 Pt 1):1231-1237; discussion 1237.
8. Konety BR, Allareddy V, Herr H. Complications after radical cystectomy: analysis of population-based data. Urology. 2006;68(1):58-64.
9. Lowrance WT, Rumohr JA, Chang SS, Clark PE, Smith JA Jr, Cookson MS. Contemporary open radical cystectomy: analysis of perioperative outcomes. J Urol. 2008;179(4):1313-1318; discussion 1318.
10. Takada N, Abe T, Shinohara N, et al. Peri-operative morbidity and mortality related to radical cystectomy: a multi-institutional retrospective study in Japan. BJU Int. 2012;110(11 Pt B):E756-764.
11. Lee RK, Abol-Enein H, Artibani W, et al. Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes. BJU Int. 2014;113(1):11-23.
12. Nabi G, Yong SM, Ong E, McPherson G, Grant A, N’Dow J. Is orthotopic bladder replacement the new gold standard? Evidence from a systematic review. J Urol. 2005;174(1):21-28.
13. Witjes JA, Comperat E, Cowan NC, et al. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol. 2014;65(4):778-792.
14. Hautmann RE, Abol-Enein H, Hafez K, et al. Urinary diversion. Urology. 2007;69(1 Suppl):17-49.
15. Montie JE, Clark PE, Eisenberger MA, et al. Bladder cancer. J Natl Compr Canc Netw. 2009;7(1):8-39.
16. Kim SP, Shah ND, Weight CJ, et al. Population-based trends in urinary diversion among patients undergoing radical cystectomy for bladder cancer. BJU Int. 2013;112(4):478-484.
17. Aziz A, May M, Burger M, et al. Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort. Eur Urol. 2014;66(1):156-163.
18. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1-266.
19. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.
20. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205-213.
21. Mitropoulos D, Artibani W, Graefen M, Remzi M, Roupret M, Truss M. Reporting and grading of complications after urologic surgical procedures: an ad hoc EAU guidelines panel assessment and recommendations. Eur Urol. 2012;61(2):341-349.
22. Pannek J, Senge T. History of urinary diversion. Urol Int. 1998;60(1):1-10.
23. Somani BK, Nabi G, Wong S, et al. How close are we to knowing whether orthotopic bladder replacement surgery is the new gold standard? Evidence from a systematic review update. Urology. 2009;74(6):1331-1339.
24. May M, Stief C, Brookman-May S, et al. Gender-dependent cancer-specific survival following radical cystectomy. World J Urol. 2012;30(5):707-713.
25. Roghmann F, Trinh QD, Braun K, et al. Standardized assessment of complications in a contemporary series of European patients undergoing radical cystectomy. Int J Urol. 2014;21(2):143-149.
26. Singer S, Ziegler C, Schwalenberg T, Hinz A, Gotze H, Schulte T. Quality of life in patients with muscle invasive and non-muscle-invasive bladder cancer. Support Care Cancer. 2013;21(5):1383-1393.
27. Fajkovic H, Halpern JA, Cha EK, et al. Impact of gender on bladder cancer incidence, staging, and prognosis. World J Urol. 2011;29(4):457-463.
28. Shariat SF, Sfakianos JP, Droller MJ, Karakiewicz PI, Meryn S, Bochner BH. The effect of age and gender on bladder cancer: a critical review of the literature. BJU Int. 2010;105(3):300-308.
29. Gore JL, Saigal CS, Hanley JM, Schonlau M, Litwin MS. Variations in reconstruction after radical cystectomy. Cancer. 2006;107(4):729-737.
30. Van Poppel H, Sorgeloose T. Radical cystectomy with or without urethrectomy? Crit Rev Oncol Hematol. 2003;47(2):141-145.
31. Anderson CB, Cookson MS, Chang SS, Clark PE, Smith JA Jr, Kaufman MR. Voiding function in women with orthotopic neobladder urinary diversion. J Urol. 2012;188(1):200-204.
32. Stein JP, Penson DF, Lee C, Cai J, Miranda G, Skinner DG. Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer. J Urol. 2009;181(5):2052-2058; discussion 2058-2059.
33. Jentzmik F, Schrader AJ, de Petriconi R, et al. The ileal neobladder in female patients with bladder cancer: long-term clinical, functional, and oncological outcome. World J Urol. 2012;30(6):733-739.
34. Gore JL, Yu HY, Setodji C, Hanley JM, Litwin MS, Saigal CS. Urinary diversion and morbidity after radical cystectomy for bladder cancer. Cancer. 2010;116(2):331-339.
35. Leow JJ, Reese S, Trinh QD, et al. The impact of surgeon volume on the morbidity and costs of radical cystectomy in the United States: a contemporary population-based analysis. BJU Int. Epub 27 Mar 2014. doi: 10.1111/bju.12749.
36. Rink M, Dahlem R, Kluth L, et al. Older patients suffer from adverse histopathological features after radical cystectomy. Int J Urol. 2011;18(8):576-584.
37. Donat SM, Wei DC, McGuire MS, Herr HW. The efficacy of transurethral biopsy for predicting the long-term clinical impact of prostatic invasive bladder cancer. J Urol. 2001;165(5):1580-1584.
38. Akkad T, Gozzi C, Deibl M, et al. Tumor recurrence in the remnant urothelium of females undergoing radical cystectomy for transitional cell carcinoma of the bladder: long-term results from a single center. J Urol. 2006;175(4):1268-1271; discussion 1271.
39. Stein JP, Penson DF, Wu SD, Skinner DG. Pathological guidelines for orthotopic urinary diversion in women with bladder cancer: a review of the literature. J Urol. 2007;178(3 Pt 1):756-760.